Posted in | News

Sweco Buys Axro's Consulting Engineering Firm

Sweco has acquired the consulting engineering firm of Axro Consult AB with 35 employees.

Axro has cutting-edge expertise in building service systems for the healthcare sector and a customer list that includes some 20 different hospitals. Axro has offices in Gothenburg, Jönköping and Skövde, and the acquisition will establish Sweco with a new office in Skövde.

“Sweco’s healthcare assignments have increased continuously. At the moment we are working on projects such as the New Karolinska University Hospital in Solna and Sahlgrenska University Hospital in Gothenburg. Axro’s healthcare expertise will further enhance Sweco’s competitiveness and will also expand our geographical presence with a new office in Skövde,” says Eva Nygren, President of Sweco Sweden.

“By becoming part of Sweco we can offer both our customers and employees a wider range of competencies and the capacity to take on larger assignments. It feels like a step in the right direction,” says Anders Walter, President of Axro Consult.

Sweco has collaborated with Axro for many years. As early as 1958 the two companies started a joint project at Volvo’s new automobile factory in Torslanda, a partnership that lasted until 1989.

Following the acquisition, Sweco will have offices at 50 locations in Sweden.

Source: http://www.sweco.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.